{"nct_id":"NCT03005327","title":"A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2016-12","start_date_type":"ACTUAL","primary_completion_date":"2022-06-16","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["XFOR"]}